Last Updated: September 24, 2026

Details for New Drug Application (NDA): 020919

✉ Email this page to a colleague

« Back to Dashboard

NDA 020919 describes GEODON, which is a drug marketed by Viatris and Pfizer Inc and is included in three NDAs. It is available from two suppliers. Additional details are available on the GEODON profile page.

The generic ingredient in GEODON is ziprasidone mesylate. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ziprasidone mesylate profile page.

Summary for 020919

Tradename:	GEODON
Applicant:	Viatris
Ingredient:	ziprasidone mesylate
Patents:	0

Pharmacology for NDA: 020919

Suppliers and Packaging for NDA: 020919

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
GEODON	ziprasidone mesylate	POWDER;INTRAMUSCULAR	020919	NDA	Viatris Specialty LLC	58151-137	58151-137-81	10 VIAL in 1 CARTON (58151-137-81) / 1 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	POWDER;INTRAMUSCULAR			Strength	EQ 20MG BASE/VIAL
Approval Date:	Jun 21, 2002	TE:	AP	RLD:	Yes

Expired US Patents for NDA 020919

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Viatris	GEODON	ziprasidone mesylate	POWDER;INTRAMUSCULAR	020919-001	Jun 21, 2002	⤷ Start Trial	⤷ Start Trial
Viatris	GEODON	ziprasidone mesylate	POWDER;INTRAMUSCULAR	020919-001	Jun 21, 2002	⤷ Start Trial	⤷ Start Trial
Viatris	GEODON	ziprasidone mesylate	POWDER;INTRAMUSCULAR	020919-001	Jun 21, 2002	⤷ Start Trial	⤷ Start Trial
Viatris	GEODON	ziprasidone mesylate	POWDER;INTRAMUSCULAR	020919-001	Jun 21, 2002	⤷ Start Trial	⤷ Start Trial
Viatris	GEODON	ziprasidone mesylate	POWDER;INTRAMUSCULAR	020919-001	Jun 21, 2002	⤷ Start Trial	⤷ Start Trial
Viatris	GEODON	ziprasidone mesylate	POWDER;INTRAMUSCULAR	020919-001	Jun 21, 2002	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.